"10.1371_journal.pone.0048721","plos one","2012-11-16T00:00:00Z","Fabien Abdul; Bénédicte Ndeboko; Thierry Buronfosse; Fabien Zoulim; Michael Kann; Peter E Nielsen; Lucyna Cova","Université de Lyon 1, Lyon, France; Institut National de la Santé et de la Recherche Medicale (INSERM) U1052, Centre de Recherche en Cancérologie de Lyon (CRCL), Lyon, France; CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France; VetAgro-Sup, Marcy lEtoile, France; Université de Bordeaux, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France; CNRS, Microbiologie fondamentale et Pathogénicité, UMR 5234, Bordeaux, France; CHU de Bordeaux, Bordeaux, France; Department of Cellular and Molecular Medicine and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, The Panum Institute, University of Copenhagen, Copenhagen N, Denmark","Conceived and designed the experiments: LC MK PN FZ FA. Performed the experiments: FA BN TB. Analyzed the data: LC FA TB MK. Contributed reagents/materials/analysis tools: PN MK. Wrote the paper: FA LC MK PN. Made major contribution in demonstration of drastic inhihibition of hepadnavirus replication by a modified cell penetrating peptide: FA BN.","The authors have declared that no competing interests exist.","2012","11","Fabien Abdul","FA",7,FALSE,5,3,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
